Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2016-12-05 11:03:13 |
Versijas komentārs | |
Teksts |
Olainfarm will
hold Third Quarter 2016 Investor Conference Webinar
AS „Olainfarm”
invites shareholders, investors, mass media representatives and
other stakeholders to join its investor conference webinar
scheduled on December 8, 2016 at 16:00 (EET). Please note
that attendees have to register for the webinar in advance –
detailed information on the registration process is available
below. Webinar will be
hosted by the Member of the Management Board Salvis Lapiņš. The
presentation will be held in English. During the webinar
Salvis Lapiņš
will inform about AS “Olainfarm” activities and financial results
of third quarter of 2016. After the
presentation investors are welcome to ask questions. Due to
the limited webinar time, please send in your questions in
advance till December 7 to e-mail:
eva.dzerve@nasdaq.com.
Registration
process You will be provided with the
webinar link and instructions to join webinar successfully. When
joining the webinar for the first time, you will be asked to
download the system application on your computer which will take
only few seconds. What is a
corporate webinar?
JSC Olainfarm is one of the
biggest pharmaceutical companies in Latvia with more than 40 years
of experience in production of medication and chemical and
pharmaceutical products. A basic principle of company's operations
is to produce reliable and effective top quality products for
Latvia and the rest of the world. Products made by the Group are
being exported to more than 35 countries of the world, including
the Baltics, Russia, other CIS, Europe, Asia, North America and
Australia. Information
prepared by: |
Pielikumi |
|